Speak directly to the analyst to clarify any post sales queries you may have.
The global Peripherally Inserted Central Catheter market is evolving as healthcare leaders prioritize efficiency, innovation, and new approaches to clinical care. Senior decision-makers in the sector face opportunities to drive better outcomes and optimize procurement strategies, responding to the ongoing demands of modern healthcare delivery.
Market Snapshot: Global Peripherally Inserted Central Catheter Market
The global Peripherally Inserted Central Catheter (PICC) market demonstrated consistent growth in 2024, reaching a valuation of USD 1.03 billion, with projections indicating a rise to USD 1.07 billion in 2025 and an estimated compound annual growth rate (CAGR) of 4.00%. By 2032, analysts expect the market to achieve a value of USD 1.41 billion. This upward trend is attributed to ongoing advances in material science, increased adoption of PICCs in outpatient and home settings, and strengthened supply chain strategies. Demand for long-term vascular access solutions is rising, shaping opportunities for providers across hospitals, ambulatory centers, and home health agencies as clinical practices and procurement priorities evolve.
Scope & Segmentation of the Peripherally Inserted Central Catheter Market
This report delivers segmentation that supports executive decision-making in procurement, clinical implementation, and strategic planning related to the Peripherally Inserted Central Catheter market. The analysis examines factors driving engagement across both established and emerging healthcare landscapes, helping organizations align with current and future needs.
- Product Types: Encompasses open ended coaxial catheters, power injectable catheters, and valved coaxial catheters, all designed for flexibility with single-lumen and multi-lumen configurations. Diverse product features enable tailored use across varying procedural demands.
- Material Types: Examines polyurethane catheters, which now include antimicrobial-coated versions, as well as silicone catheters equipped with antithrombogenic coatings. These enhancements drive compatibility and play a critical role in infection prevention.
- End User Segments: Highlights the operational needs and workflow patterns typical of ambulatory surgery centers, dialysis centers, home care providers, and hospitals serving a wide spectrum of patient populations.
- Clinical Indications: Assesses applications in both acute and chronic care, from antibiotic delivery and chemotherapy (for both hematologic and solid tumors) to intravenous therapies, hydration, pain management, and parenteral nutrition.
- Distribution Channels: Explores hospital and retail pharmacy models alongside online procurement platforms, reflecting shifts in inventory management practices and the rise of digital ordering systems among healthcare providers.
- Regional Coverage: Provides market insights and segmentation for key global regions such as the Americas, EMEA, and Asia-Pacific, with in-depth analysis dedicated to the United States, China, India, Japan, Australia, and South Korea. These regions are shaping differentiated market dynamics and procurement approaches.
- Technology Trends: Evaluates uptake of antimicrobial and antithrombogenic coatings, increased adoption of digital workflows, and the integration of power-injectable and multi-lumen catheter technologies. These advances facilitate safety, patient outcomes, and workflow improvements.
Key Takeaways for Senior Decision-Makers
- PICCs are central to critical care pathways, supporting oncology treatments, infection control, and nutritional or infusion therapy as patient-centric and value-based models become more prominent.
- Adoption of biocompatible catheter materials and digital monitoring platforms helps minimize infection rates, optimize procedural flows, and deliver durable solutions adaptable to complex patient needs.
- Simulation-based procurement strategies are enhancing staff training and advancing patient safety metrics, supporting continuous supply chain performance improvements.
- Device manufacturers, healthcare providers, and regulatory stakeholders are cultivating partnerships to expand access and facilitate rapid adoption of advanced catheter technologies in varied care contexts.
- Growth in direct purchasing methods and the expansion of online distribution channels contribute to agile inventory management, ensuring facilities can respond quickly to changing clinical demand.
- Diverse product portfolios enable precise matching of device specifications to clinical needs, refining care planning and reducing unnecessary procedures.
Tariff Impact on Supply Chain Dynamics
Recent tariffs on imported PICC components within the United States have heightened cost pressures across the supply chain. In response, domestic suppliers are scaling up polymer manufacturing capacity while original equipment manufacturers adjust sourcing and supplier relationships. These measures serve to strengthen supply quality, sustain workflow, and ensure organizations maintain standards of patient care despite evolving regulatory requirements.
Methodology & Data Sources
The market research draws from regulatory filings, clinical practice guidelines, and supplier documentation, combined with interviews involving clinicians, procurement specialists, and material science experts. Validation was conducted through surveys of manufacturers and distributors, supporting the accuracy and relevance of the findings.
Why This Report Matters
- Equips executive teams with a complete market review, enabling prioritization of high-value segments and informed investment in technology-driven innovation.
- Delivers benchmarking tailored to research, procurement, and commercialization strategies, supporting transformation efforts in healthcare supply chains.
- Provides the strategic foresight to address supply chain and technology integration challenges, helping organizations build resilience and enhance operational continuity.
Conclusion
As clinical and technological advancements reshape the Peripherally Inserted Central Catheter market, organizations focused on agility and digital integration are better positioned to deliver effective, resilient healthcare solutions.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
Companies Mentioned
The companies profiled in this Peripherally Inserted Central Catheter market report include:- Becton Dickinson and Company
- B. Braun Melsungen AG
- Teleflex Incorporated
- AngioDynamics, Inc.
- ICU Medical, Inc.
- Medtronic plc
- Cook Medical LLC
- Merit Medical Systems, Inc.
- Smiths Group plc
- Terumo Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 189 |
| Published | November 2025 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 1.07 Billion |
| Forecasted Market Value ( USD | $ 1.41 Billion |
| Compound Annual Growth Rate | 4.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |


